Table 1.
Adult stem cells transplantations: Published clinical trials from the past 4 years
| Ref. | Year | No. of patients | Age range | Type of cell grafted | Adjuvant treatments | Follow-up |
| Dai et al[53] | 2013 | 20 | 22-54 yr | MSCs | - | 6 mo |
| García-Santos et al[54] | 2013 | 11 | 33-61 yr | MSCs | - | 12 mo |
| Tian et al[55] | 2013 | 97 | 21.1-38.21 yr | MSCs | - | 14 d |
| Frolov et al[56] | 2012 | 20 | 18-55 yr | HSCs | - | 48 mo |
| Karamouzian et al[20] | 2012 | 31 | 10-50 yr | BMCs | - | 33 mo |
| Martínez et al[57] | 2012 | 67 | 49.2 ± 10.31 yr | CD133+ | - | 12 mo |
| Mazzini et al[28] | 2012 | 19 | 20-75 yr | MSCs | - | 108 mo |
| Moviglia et al[47] | 2012 | 7 | 33-78 yr | NSCs | T-cell vaccine | 12 mo |
| Prasad et al[58] | 2012 | 11 | 30-70 yr | MNCs | - | 52 wk |
| Brazzini et al[59] | 2010 | 53 | 38-81 yr | BMCs | - | 1-18 mo |
| Karussis et al[26] | 2010 | 19 | 53.01 yr | MSCs | - | 25 mo |
| Lee et al[60] | 2010 | 16 | 64.0 ± 11.61 yr | MSCs | - | 5 yr |
| Venkataramana et al[61] | 2010 | 7 | 22-62 yr | MSCs | - | 12-36 mo |
1
The authors only provide mean values. MSCs: Mesenchymal stem cells; HSCs: Hematopoietic stem cells; BMCs: Bone marrow stem cells; NSCs: Neural stem cells; MNCs: Mononuclear cells from bone marrow.